Patents/Assignees

KATMAI PHARMACEUTICALS, Inc.

1 patent in portfolio

US12545686utility2026
Polymorphic Forms of (s)-n-(3-bromo-2-fluorophenyl)-7-((4-methylpiperazin-1-yl)methyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine as EGFR Inhibitors
0 cites